Product Details:
| Strength | 450 mg/45ml |
| Pack Size | 45 ml |
| Pack Type | Vial |
| Brand Name | Carbokast |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Shelf Life | 24 Months |
| Usages | To treat certain types of cancer |
| Prescription/Non prescription | Prescription |
| Form | Injection |
| Composition | Carboplatin 450MG |
Carbokast (Carboplatin Injection 450 mg/45 ml) is a high-quality, hospital-grade oncology medication used in the treatment of various cancers, including ovarian cancer, lung cancer, head & neck cancers, and other solid tumors. Manufactured under stringent quality standards, Carbokast ensures reliable efficacy, safety, and compliance with global pharmacopeial norms.
Formulated with Carboplatin, a second-generation platinum-based antineoplastic agent, Carbokast works by inhibiting DNA replication in cancer cells, thereby slowing or stopping tumor growth. The injection is supplied in a 45 ml sterile vial, suitable for IV infusion, and designed for use under the supervision of qualified healthcare professionals.
Carbokast is widely preferred by oncologists for its consistent performance, predictable toxicity profile, and better tolerability compared to first-generation platinum agents. It is commonly used alone or in combination chemotherapy regimens.
Key Features:
Strength: 450 mg/45 ml
Active Ingredient: Carboplatin
Brand: Carbokast
Dosage Form: Intravenous Injection
Usage: Treatment of ovarian, lung, and multiple solid tumors
Quality: Manufactured in WHO-GMP certified facility
Packaging: Single-use glass vial with secure flip-off seal
Availability: Ready stock for export & domestic supply
Carbokast offers dependable therapeutic value and is suitable for hospitals, cancer centres, pharmacies, and distributors seeking a trusted oncology product.
Product Details:
| Strength | 40 mg |
| Packaging Type | Vial |
| Prescription/Non-prescription | Prescription |
| Brand | Mitomycin |
| Manufacturer | Zydus |
| Country of Origin | Made in India |
| Form | Lyophilized Form |
| Storage Condition | Store between 15 DegreeC to 30 DegreeC. Protect from Light |
Mitomycin 40MG Injection is an antineoplastic (chemotherapy) medication used for the treatment of various types of cancers, including stomach, pancreas, and bladder cancer, as prescribed by an oncologist. It works by inhibiting the growth and spread of cancer cells in the body.
Key Features:
Strength: 40 mg per vial
Form: Lyophilized powder for injection
Route: Intravenous use under medical supervision
Packaging: Single-use vial
Storage: Store in a cool, dry place, protected from light
Uses:
Treatment of advanced stomach cancer
Treatment of pancreatic cancer
Palliative treatment in bladder cancer and other solid tumors
Precautions:
To be administered only by qualified healthcare professionals
Not for self-administration
Regular monitoring of blood counts and kidney function advised during treatment
Available with us at competitive prices with assured quality and prompt supply for your hospital and oncology needs.
Product Details:
| Strength | 40 mg |
| Packaging Type | Vial |
| Prescription/Non-prescription | Prescription |
| Country of Origin | Made in India |
| Form | Lypophilized |
Genmycin (Mitomycin 40mg) is an anti-cancer chemotherapy medication used in the treatment of various types of cancers. It works by inhibiting the growth of cancer cells and preventing their spread in the body. Mitomycin is commonly prescribed in combination with other chemotherapy drugs for enhanced effectiveness.
Key Features:
Brand Name: Genmycin
Generic Name: Mitomycin
Strength: 40mg
Form: Injection
Usage: Hospital / Clinical
Application: Oncology / Cancer Treatment
Therapeutic Uses:
Stomach Cancer
Pancreatic Cancer
Bladder Cancer
Other solid tumors as prescribed by oncologists
Packaging:
Vial packaging for injection use
Available in standard export-quality packing
Storage:
Store below 25°C in a dry place
Protect from light and moisture
Disclaimer:
Genmycin (Mitomycin 40mg) should be used only under the supervision of a qualified oncologist.
Product Details:
| Strength | 10.8 mg |
| Packaging Type | Box |
| Brand | Zoladex |
| Manufacturer | AstraZeneca |
| Shelf Life | 36 Months |
Zoladex (Goserelin 10.8MG) is a long-acting gonadotropin-releasing hormone (GnRH) agonist, used in the treatment of hormone-sensitive cancers and certain gynecological conditions. It is commonly prescribed for:
Prostate cancer (advanced or locally advanced)
Breast cancer in pre-menopausal women
Endometriosis
Uterine fibroids
As part of assisted reproduction protocols
Zoladex works by regulating hormone levels to suppress the production of testosterone or estrogen, helping control the progression of hormone-dependent conditions.
Key Features:
Each implant contains: Goserelin Acetate 10.8MG
Form: Subcutaneous implant (one dose lasts 12 weeks)
Administration: Administered by a healthcare professional
Packaging: Sterile pre-filled syringe with protective packaging
Storage: Store below 25°C, protect from light and moisture
Benefits:
✅ Sustained hormone suppression with a single 12-week dose
✅ Effective management of hormone-responsive diseases
✅ Widely used in oncology and reproductive medicine
Note:
To be used under medical supervision only. Not for self-administration.
Product Details:
| Strength | 3.6 mg |
| Packaging Type | Vial |
| Brand | Zoladex |
| Manufacturer | AstraZeneca |
| Form | Injection |
| Composition | Goserelin Acetate Implant Injection BP |
| Treatment | Prostate Cancer |
Zoladex (Goserelina 3.6MG) is a luteinizing hormone-releasing hormone (LHRH) agonist used in the treatment of hormone-sensitive cancers and other hormone-related conditions. It is commonly prescribed for prostate cancer, breast cancer, and endometriosis, as well as for uterine fibroids and to thin the endometrium before surgery.
Zoladex works by suppressing the production of certain hormones, effectively controlling disease progression in hormone-responsive tumors.
Key Features:
Composition: Goserelin Acetate 3.6MG (as a depot formulation)
Indications:
Prostate cancer
Breast cancer in premenopausal women
Endometriosis
Uterine fibroids
Endometrial thinning prior to surgery
Dosage Form: Subcutaneous implant (depot)
Administration: Once every 28 days by healthcare professional
Packaging: Sterile single-use pre-filled syringe
Storage: Store in a cool, dry place (below 25°C); protect from light
Highlights:
Long-acting formulation ensures consistent hormone suppression
Manufactured under strict quality standards
Widely recommended by oncologists and gynecologists
Note:
To be administered by trained medical professionals. Use only under medical supervision.
Product Details:
| Strength | 3.5 mg |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Prescription/Non-prescription | Prescription |
| Brand | Bortenat |
| Manufacturer | Natco Pharma |
Bortenat 3.5MG (Bortezomib 3.5mg Injection) is an anti-cancer medication used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to the class of proteasome inhibitors, helping to prevent the growth and spread of cancer cells within the body.
Composition:
Each vial contains Bortezomib 3.5mg as a lyophilized powder for reconstitution.
Packing:
Pack of 1 vial.
Usage:
Administered under the supervision of a qualified healthcare professional in a hospital or clinical setup.
Key Features:
✅ WHO GMP Certified manufacturing
✅ Effective in treating multiple myeloma and mantle cell lymphoma
✅ High purity and quality standards
✅ Reliable supply and competitive pricing
Storage:
Store in a refrigerator (2°C – 8°C).
Keep out of reach of children.
Note: Bortenat 3.5MG should only be used under medical supervision and as prescribed by an oncologist.
Product Details:
| Strength | 2 mg |
| Packaging Type | Vial |
| Country of Origin | Made in India |
| Prescription/Non-prescription | Prescription |
| Brand | Bortenat |
| Manufacturer | Natco Pharma |
Bortenat 2MG (Bortezomib 2mg Injection) is an anticancer medication used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to the class of proteasome inhibitors, helping to stop the growth and spread of cancer cells in the body.
Key Features:
Contains Bortezomib 2mg per vial
Helps in the management of multiple myeloma and mantle cell lymphoma
Administered under the supervision of a healthcare professional
Manufactured under WHO-GMP certified facilities ensuring quality and safety
Packaging: Single-use vial
Storage: Store in a refrigerator (2°C – 8°C). Do not freeze.
Usage: To be used strictly under medical supervision only.
Availability: Ready stock available for hospitals, cancer treatment centers, and oncology distributors.
Product Details:
| Strength | 11.25 mg |
| Packaging Type | Box |
| Prescription/Non-prescription | Prescription |
| Manufactured by | Bharat Serums and Vaccines Limited |
| Shelf Life | 2 Years |
| Storage | Store Below 25°C. Do No Freeze. |
Luprodex (Leuprolide Acetate 11.5 mg) is a long-acting gonadotropin-releasing hormone (GnRH) agonist used in the management of hormone-dependent medical conditions. It works by suppressing the production of certain hormones in the body, thereby reducing the effects of testosterone in men and estrogen in women.
Therapeutic Uses:
Treatment of advanced prostate cancer in men.
Management of endometriosis and uterine fibroids in women.
Treatment of central precocious puberty (CPP) in children.
Key Features:
Sustained-release depot formulation providing 3-month hormone suppression.
Manufactured under WHO-GMP-certified facilities ensuring international quality standards.
Precise dosage for effective and safe therapy.
Stringent quality control with assured efficacy and stability.
Storage: Store below 25°C. Protect from light. Do not freeze.
Administration: To be administered under medical supervision only.
Note: Luprodex is for hospital/institutional use and prescription sale only.
Product Details:
| Strength | 22.5 mg |
| Packaging Type | Box |
| Prescription/Non-prescription | Prescription |
| Manufactured by | Bharat Serums and Vaccines Limited |
| Storage Conditions | Store below 25°C. Do not freeze. |
| Shelf Life | 2 Years |
Luprodex 22.5 mg Injection contains Leuprolide Acetate, a synthetic gonadotropin-releasing hormone (GnRH) agonist used for the management of hormone-dependent conditions. It works by reducing the levels of certain hormones in the body, such as testosterone in men and estrogen in women, thereby helping control diseases influenced by these hormones.
Therapeutic Uses:
Advanced Prostate Cancer
Endometriosis and Uterine Fibroids
Precocious Puberty (in children)
Hormone-responsive breast cancer (in select cases)
Mechanism of Action:
Leuprolide initially increases, then markedly decreases, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, leading to suppression of gonadal steroid production.
Key Features:
Long-acting 3-month depot formulation
Ensures consistent hormone suppression
Manufactured under WHO-GMP certified facilities
Stringent quality and sterility standards
Storage: Store below 25°C. Protect from light.
Product Details:
| Strength / Dose | 40 mg / 0.8 ml |
| Manufacturer | Zydus |
| Packaging Type | Pre Filled Syringe |
| Storage Temperature | Store between +2 DegreeC and +8 DegreeC |
| Composition | Adalimumab |
| Shelf Life | 36 Months |
| Usage | Rheumatoid arthritis |
| Prescription/Non-Prescription | Prescription |
| Instructions | Protect from light. Do not freeze |
Exemptia (Adalimumab 40mg/0.8ml) is a TNF (Tumor Necrosis Factor) inhibitor used for the treatment of various autoimmune conditions. It is a biosimilar to Humira and is indicated for diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.
This injectable biologic medicine works by blocking TNF-alpha, a protein involved in inflammation, thereby helping to reduce pain, swelling, and joint damage.
Key Features:
Biosimilar to globally accepted Humira
Administered via subcutaneous injection
Available in pre-filled syringe for ease of use
Manufactured under stringent quality standards
Usage:
To be administered under the supervision of a qualified healthcare provider. Dosage and duration depend on the specific condition being treated.
Storage:
Store in a refrigerator (2°C – 8°C). Do not freeze. Keep out of reach of children.
Note:
This is a prescription medication. Use only under medical supervision.
Product Details:
| Dose/Strength | 450 mg |
| Packaging Type | Vial |
| Packaging Size | 45 ml |
| Brand | Kemocarb |
| Manufactured By | Fresenius Kabi |
| Shelf Life | 2 YEARS |
| Storage Instruction | Store at 15° - 30° C |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
| Form | Injection |
Carboplatin Injection 450 mg/45 ml is a platinum-based chemotherapy medicine widely used for the treatment of various solid tumors. Manufactured to high quality and pharmacopeial standards, this injection is designed to provide reliable therapeutic effect with improved tolerability compared to earlier platinum analogues. The active ingredient, Carboplatin, works by interfering with the DNA synthesis of cancer cells, thereby preventing their growth and replication.
Indications:
Carboplatin is commonly prescribed for the treatment of ovarian cancer, lung cancer (NSCLC), head & neck cancers, and other malignancies as advised by oncologists. It is used either as a single agent or in combination with other chemotherapeutic drugs depending on the treatment protocol.
Strength and Pack:
• Strength: Carboplatin 450 mg
• Pack: 45 ml sterile injection vial
• Brand Available: Kemocarb (well-recognized and widely preferred brand in Oncology)
Key Features:
• High-quality formulation ensuring optimal efficacy and safety
• Ready-to-use sterile liquid injection
• Produced in WHO-GMP certified facilities
• Suitable for hospital, oncology centers, and large-scale procurement
• Stable supply with assured product authenticity
Usage:
To be administered only under the supervision of qualified healthcare professionals. Dosage depends on patient’s body surface area, renal function, and clinical condition.
Storage:
Store below 25°C. Protect from light. Keep out of reach of children.
This product is intended strictly for pharmaceutical distribution, hospital procurement, and regulated oncology therapy use.
Product Details:
| Strength | 0.5 mg/ml |
| Packaging Type | Vial |
| Packaging Size | 2 ml Vial |
| Prescription/Non prescription | Prescription |
| Country of origin | Made in India |
| Brand | Teceris |
| Manufacturer | Mylan |
Teceris (Eribulin Mesylate Injection) is a chemotherapy medication used in the treatment of advanced or metastatic breast cancer and liposarcoma. It is formulated as a 0.5 mg/ml sterile solution for intravenous injection and works by inhibiting the growth of cancer cells through microtubule dynamics disruption.
This medication is typically administered under the supervision of an oncology specialist and is indicated for patients who have previously received certain other chemotherapy treatments.
Key Features:Used in treatment of late-stage breast cancer and soft tissue sarcoma
Contains Eribulin Mesylate 0.5 mg/ml
Provided in a sterile injectable form
Ensures high efficacy and consistent results
Complies with international pharmaceutical standards
Teceris is to be administered intravenously, typically on days 1 and 8 of a 21-day cycle, or as prescribed by the treating oncologist.